Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protease, serine 11F (TMPRSS11F) is a type II transmembrane serine protease mainly found at the cell surface of diverse epithelial tissues and exocrine glands[1][2][3][5]. It plays an essential role in epidermal barrier formation and maintenance, facilitating proteolysis required for normal skin function and hydration[1][2][3]. Studies in knockout mice show its importance in preventing trans-epidermal fluid loss, especially in neonates[1][2]. Abnormal expression in cancer, specifically acute myeloid leukemia, is correlated with poor prognosis and promotes cancer cell invasion via activation of matrix metalloproteinase-2[1]. There are no documented drug interactions or approved targeted therapies, but the molecule is being explored as a cell surface biomarker and as a candidate therapeutic target in oncology[1][2][3][5].
not established for approved drugs; mechanism described in cancer is activation of matrix metalloproteinase-2 facilitating cancer invasion[1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protease, serine 11F (TMPRSS11F).